Construction of a Nocardia brasiliensis fluorescent plasmid to study Actinomycetoma pathogenicity

Plasmid

Volumn 65, Issue 1, 2011, Pages 25-31

  Salinas Carmona, Mario C ^a   Rocha Pizaña, María R ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Fluorescent plasmid; Mycetoma; Nocardia brasiliensis; Phatogenicity

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ACTINOMYCETOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIABILITY; BACTERIAL VIRULENCE; CONTROLLED STUDY; MOUSE; NOCARDIA BRASILIENSIS; NONHUMAN; PLASMID; REPORTER GENE;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; NOCARDIA BRASILIENSIS;

EID: 78650722762     PISSN: 0147619X     EISSN: 10959890     Source Type: Journal    
DOI: 10.1016/j.plasmid.2010.09.005     Document Type: Article

References (16)

1. Beaman B.L., Beaman L. Nocardia species: host-parasite relationships. Clin. Microbiol. Rev. 1994, 7(2):213-264.
2. Beuzón C.R., Salcedo S.P., Holden D.W. Growth and killing of a Salmonella enterica serovar Typhimurium sifA mutant strain in the cytosol of different host cell lines. Microbiology 2002, 148(Pt 9):2705-2715.
3. Casey W.M., Nguyen N.A. Use of the green fluorescent protein to rapidly assess viability of E Coli in preserved solutions. PDA. J. Pharm. Sci. Technol. 1996, 50:352-355.
4. Chiba K., Hoshino Y., Ishino K., Kogure T., Mikami Y., Uehara Y., Ishikawa J. Construction of a pair of practical Nocardia-Escherichia coli shuttle vectors. Jpn. J. Infect. Dis. 2007, 60(1):45-47.
5. Fish D.N., Danziger L.H. Neglected pathogens: bacterial infections in persons with human immunodeficiency virus infection A review of the literature. Pharmacotherapy 1993, 13(5):415-439.
6. Hoshino Y., Fujii S., Shinonaga H., Arai K., Saito F., Fukai T., Satoh H., Miyazaki Y., Ishikawa J. Monooxygenation of rifampicin catalyzed by the rox gene product of Nocardia farcinica: structure elucidation, gene identification and role in drug resistance. J. Antibiot. 2010, 63(1):23-28.
7. Hoogeveen M., Brouwer R.E., Bernards A.S., Soetekouw R. Nocardiosis an important opportunistic infection. Ned. Tijdschr. Geneeskd. 6 2010, 154(5):A1177.
8. Hubble J.P., Cao T., Kjelstrom J.A., Koller W.C., Beaman B.L. Nocardia species as an etiologic agent in Parkinson's disease: serological testing in a case-control study. J. Clin. Microbiol. 1995, 33:2768-2769.
9. Ishikawa J., Yamashita A., Mikami Y., Hoshino Y., Kurita H., Hotta K., Shiba T., Hattori M. The complete genomic sequence of Nocardia farcinica IFM 10152. Proc. Natl. Acad. Sci. USA 2004, 101:14925-14930.
10. López-Martinez R., Mendez-Tovar L., Lavalle P., Welsh O., Saul A., Macotela-Ruiz E. Epidemiology of mycetoma in Mexico: study of 2105 cases. Gac. Med. Mex. 1992, 128(4):477-481.
11. Pruitt A.A. Nervous system infections in patients with cancer. Neurol. Clin. 2003, 21(1):193-219.
12. Salinas-Carmona M.C., Torres-López E., Ramos A.I., Licón-Trillo A., González-Spencer D. Immune response to Nocardia brasiliensis antigen in an experimental model of actinomycetoma in BALB/c mice. Infect. Immun. 1999, 67:2428-2432.
13. Salinas-Carmona, M.C., (2000). Nocardia brasiliensis: from microbe to human and experimental infections. Review. Microb & Infect. 2. 1373-1381.
14. Vento S., Cainelli F., Temesgen Z. Lung infections after cancer chemotherapy. Lancet Oncol. 2008, 9(10):982-992.
15. Vera-Cabrera L., Espinoza-González N.A., Welsh O., Ocampo-Candiani J., Castro-Garza J. Activity of novel oxazolidinones against Nocardia brasiliensis growing within THP-1. J. Antimicrob. Chemother. 2009, 64:1013-1017.
16. Welsh O., Vera-Cabrera L., Salinas-Carmona M. Mycetoma. Clin. Dermatol. 2007, 25:195-202.